Table 3 Comparison between the younger group (≦50 years) and older group (> 50 years) regarding the changes in median CFT and BCVA (logMAR)
From: Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Parameter | ≦ 50 years | > 50 years | p a | ||||
|---|---|---|---|---|---|---|---|
Median | IQR [range] | Min-Max | Median | IQR [range] | Min-Max | ||
Change in median CFT (μm) | −52.00 | 78.75 [− 106.75- -28.00] | − 109-4.00 | − 30.00 | 26 [− 33.00- -7.00] | −1.28- -0.10 | 0.038 |
Change in BCVA (logMAR) | |||||||
Three months after aflibercept injection | − 0.42 | 0.88 [− 0.78- -0.10] | −1.10-0.01 | − 0.30 | 0.36 [− 0.46- -0.10] | − 1.28- -0.10 | 0.831 |
Twelve months after aflibercept injection | − 0.42 | 0.71 [− 0.81- -0.10] | − 1.25-0.16 | − 0.34 | 0.64 [− 0.84- -0.20] | −73.00-45.00 | 0.832 |